Russia Keen to Sell MiG-35 to Indian Air Force: Official

Agencies
July 23, 2017

New Delhi, Jul 23: Russia is keen on selling its new fighter jet MiG-35 to India with the MiG corporation's chief saying the country has evinced interest in the aircraft and talks were on to understand its requirements. Chief Executive Officer of the MiG Aircraft Corporation Ilya Tarasenko said that after having presented MiG-35 in January, the MiG corporation began to actively promote the aircraft in India and in other parts of the world.

"We are proposing supply of the aircraft for tenders in India and we (are) actively work with its Air Force in order to win the tender," he said while talking to reporters on the sidelines of the MAKS 2017 air show here.

The MiG-35 is Russia's most advanced 4++ generation multipurpose fighter jet developed on the basis of the serial-produced MiG-29K/KUB and MiG-29M/M2 combat aircraft. Asked if India has expressed any interest in the MiG-35, Mr Tarasenko said, "Of course they have."

MiGs have been used by India for almost 50 years and MiG corporation proposes its new products to India among the first countries and intends to continue supplying India with its most modern aircraft, the MiG chief said.

Asked about the current status of the proposal of the aircraft to India, he said, "We are in the negotiation stage where talks on technical and technological specifications that MiG can present to India and the requirements that India has for this aircraft were taking place."

"Since this is a very new plane, it will still take some time to negotiate on exactly what India needs and adjust the product to it," he added.

Talking about the cost of the plane, Mr Tarasenko said it was economical due to the after-sales services being offered along with the aircraft.

"We propose not just the aircraft, but also training for its use, as well as after-sales servicing where we take upon the responsibility to service it for 40 years," he added. He stressed that in comparison to its competitors, the prices offered by MiG were 20-25 per cent cheaper, making it an attractive option for those who wish to purchase this aircraft.

Highlighting the main features of the MiG-35, Mr Tarasenko said its technical specifications were close to a fifth generation aircraft, namely its flight capabilities, its new weapon range and defence systems, including stealth. "I would like to note the demand for this aircraft for our own air force, as well as our foreign partners. The plane is light, multi-functional and has high manoeuvrability," Mr Tarasenko said, adding that the MiG was also offering special commercial terms to its partners.

He also stressed that the plane was fully Russian-made with Rostec companies like United Engine Corporation (UEC), KRET and Technodinamika participating in the project. At MAKS 2017, the MiG-35 grabbed all the limelight as it took to the skies and enthralled the audience with breathtaking manoeuvres like the tail slide, barrel roll and the nesterov loop.

Belyaev Mikhail, the Lead Test Pilot of MiG-35, told reporters that the main feature of this aircraft was the new on board equipment and the new quality of weapons -- air-to- air, air-to-ground and air-to-sea.

"Compared with the basic version of the MiG-29, it is a new aircraft, new airframe, fly-by-wire, glass cockpit, adapted for night vision goggles...new engines, more power, more fuel, new on board equipment and new weapons," said Mikhail, who was earlier this year presented the star of the 'Hero of Russia' by President Vladimir Putin for bravery in piloting and testing of aviation equipment.

Asked if it was easier to fly MiG-35, Mikhail said new tasks were required for such an aircraft so one needs to learn these.

"On the basic level it is not that difficult to switch from MIG 29 to 35 as the plane remains the same. It is still a light simple plane. The combat tasks that can be achieved from this plane are much more serious and much more complex," he said.

"More combat tasks can be achieved from this plane than with the MiG-29. So it will take time to learn new tasks and to adapt," he added.

An overhauled MiG-35 multi-role fighter completed a successful demonstration flight at the MAKS 2017 air show, with Russian officials saying the first combat-ready plane will be delivered to the Air Force next year.

While speaking to reporters at MAKS, Mr Tarasenko also noted that around 30 countries are using various modifications of MiG-35's predecessor, the MiG-29, and that "talks are already ongoing with potential buyers."

The fighter jet features improved flight and technical characteristics, the most advanced on board radio-electronic equipment and a wide arsenal of air-to-air and air-to-surface missiles.

The flight tests of MiG-35 fighter aircraft began on January 26 and the plane's international presentation was held in the Moscow Region on the following day.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 10,2020

Tehran, Mar 10: Twenty-seven people have died from methanol poisoning in Iran after rumours that drinking alcohol can help cure the novel coronavirus infection, state news agency IRNA reported on Monday. The outbreak of the virus in Islamic republic is one of the deadliest outside of China, where the disease originated.

Twenty have died in the southwestern province of Khuzestan and seven in the northern region of Alborz after consuming bootleg alcohol, IRNA said.

Drinking alcohol is banned in Iran for everyone except some non-Muslim religious minorities. Local media regularly report on lethal cases of poisoning caused by bootleg liquor.

A spokesman for Jundishapur medical university in Ahvaz, the capital of Khuzestan, said 218 people had been hospitalised there after being poisoned.

The poisonings were caused by "rumours that drinking alcohol can be effective in treating coronavirus," Ali Ehsanpour said.

The deputy prosecutor of Alborz, Mohammad Aghayari, told IRNA the dead had drunk methanol after being "misled by content online, thinking they were fighting coronavirus and curing it." If ingested in large quantities, methanol can cause blindness, liver damage and death.

Iran has been scrambling to contain the spread of the COVID-19 illness which has hit all of the country's 31 provinces, killing 237 people and infecting 7,161.

According to IRNA, 16 out of 69 confirmed cases have died of coronavirus infection in Khuzestan as of Sunday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 23,2020

Wuhan, Feb 23: Ninety-seven more people died in China due to coronavirus, taking the death toll to 2,442, officials said on Sunday, as a team of WHO experts visited the worst-affected Wuhan city in Hubei province.

By the end of Saturday, a total of 2,442 people had died of the disease and 76,936 confirmed cases of novel coronavirus infection had been reported in 31 provincial-level regions, China's National Health Commission (NHC) said in its daily update on Sunday.

Ninety-six deaths were reported from Hubei province and one from Guangdong province on Saturday besides 648 new confirmed cases of coronavirus infections, it said.

Hubei province, where the virus first emerged in December last, reported 630 new confirmed cases, taking the total confirmed cases in the hard-hit province to 64,084, state-run Xinhua news agency reported.

The NHC also said China's daily number of newly cured and discharged novel coronavirus patients has surpassed that of new confirmed infections for the fifth consecutive day, indicating that cases of infections are coming down.

Saturday saw 2,230 people walk out of hospital after recovery, much higher than the number of the same day's new confirmed infections, which was 648, Xinhua reported.

A total of 22,888 patients infected with the novel coronavirus had been discharged from hospital after recovery by the end of Saturday, NHC said.

Meanwhile, a team of public health experts from the World Health Organisation (WHO) visited Wuhan on Saturday to conduct a detailed probe about the virus which reportedly originated from a seafood market in the city in December last year.

The NHC said WHO experts along with their Chinese counterparts who formed a joint investigation team have held talks with the local health authority in Wuhan and visited relevant healthcare institutions.

The UN team comprises specialists from the United States, Germany, Japan, Nigeria, Russia, Singapore and South Korea, Hong-Kong based South China Morning Post reported.

The 12-member team, which arrived in China on Monday, was initially designated to visit only Beijing, Guangdong and Sichuan provinces, while the worst-affected Hubei province and its capital Wuhan were missing from the list.

However, the team was finally given permission to visit Wuhan by the Chinese government.

Besides controlling the spread of the virus, a major task for the WHO team along with their Chinese counterparts was to come up with standard medicine to cure the disease.

The NHC said on Saturday that the team had met top Chinese respiratory disease expert Zhong Nanshan in Guangdong, and visited the centre for disease control and prevention in Guangdong and the city of Shenzhen, and Sichuan.

The specialists also discussed quarantine measures, the wild animal trade and community prevention measures with their Chinese counterparts, it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.